111 related articles for article (PubMed ID: 20009880)
1. CYP1A1 and CYP2D6 gene polymorphisms in Israeli Jewish women with cervical cancer.
Gutman G; Morad T; Peleg B; Peretz C; Bar-Am A; Safra T; Grisaru D
Int J Gynecol Cancer; 2009 Nov; 19(8):1300-2. PubMed ID: 20009880
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of CYP2C19 and CYP2D6 in Israeli ethnic groups.
Luo HR; Aloumanis V; Lin KM; Gurwitz D; Wan YJ
Am J Pharmacogenomics; 2004; 4(6):395-401. PubMed ID: 15651900
[TBL] [Abstract][Full Text] [Related]
3. Association of CYP1A1 and CYP2D6 gene polymorphisms with head and neck cancer in Tunisian patients.
Khlifi R; Chakroun A; Hamza-Chaffai A; Rebai A
Mol Biol Rep; 2014; 41(4):2591-600. PubMed ID: 24449363
[TBL] [Abstract][Full Text] [Related]
4. CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a North Indian population.
Sobti RC; Sharma S; Joshi A; Jindal SK; Janmeja A
Biomarkers; 2003; 8(5):415-28. PubMed ID: 14602525
[TBL] [Abstract][Full Text] [Related]
5. CYP2A6, CYP1A1, and CYP2D6 polymorphisms in lung cancer patients from central south China.
Huang FM; Chen HC; Khan MA; Yang FL; Wan XX; Xu AH; Ou-yang FD; Zhang DZ
Med Oncol; 2013 Jun; 30(2):521. PubMed ID: 23471717
[TBL] [Abstract][Full Text] [Related]
6. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of CYP2D6, CYP1A1, GSTM1 and p53 genes in a unique Siberian population of Tundra Nentsi.
Duzhak T; Mitrofanov D; Ostashevskii V; Gutkina N; Chasovnikova O; Posukh O; Osipova L; Lyakhovich VV
Pharmacogenetics; 2000 Aug; 10(6):531-7. PubMed ID: 10975607
[TBL] [Abstract][Full Text] [Related]
8. Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women.
Arbel-Alon S; Menczer J; Feldman N; Glezerman M; Yeremin L; Friedman E
Int J Gynecol Cancer; 2002; 12(6):741-4. PubMed ID: 12445252
[TBL] [Abstract][Full Text] [Related]
9. CYP1A1 and CYP2D6 Polymorphisms and Susceptibility to Chronic Myelocytic Leukaemia.
Idris HME; Khalil HB; Mills J; Elderdery AY
Curr Cancer Drug Targets; 2020; 20(9):675-680. PubMed ID: 32418524
[TBL] [Abstract][Full Text] [Related]
10. [Genetic polymorphism of CYP-1A1, CYP2D6 and risks of chronic benzene poisoning].
Gu SY; Zhang ZB; Cao DZ; Wan JX; Gao XL; Jin XP; Xia ZL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 May; 24(5):266-9. PubMed ID: 16737584
[TBL] [Abstract][Full Text] [Related]
11. Meta-analyses of the effect of CYP1A1 and CYP2D6 polymorphisms on the risk of head and neck squamous cell carcinoma.
Han J; Wang L; Yang Y; Zhang J
Oncol Res Treat; 2014; 37(7-8):406-11. PubMed ID: 25138301
[TBL] [Abstract][Full Text] [Related]
12. The risk of developing cervical cancer in Mexican women is associated to CYP1A1 MspI polymorphism.
Juárez-Cedillo T; Vallejo M; Fragoso JM; Hernández-Hernández DM; Rodríguez-Pérez JM; Sánchez-García S; del Carmen García-Peña M; García-Carrancá A; Mohar-Betancourt A; Granados J; Vargas-Alarcón G
Eur J Cancer; 2007 Jul; 43(10):1590-5. PubMed ID: 17512722
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of CYP2D6, CYP1A1 and CYP2E1 in the South-Amerindian population of Chile.
Muñoz S; Vollrath V; Vallejos MP; Miquel JF; Covarrubias C; Raddatz A; Chianale J
Pharmacogenetics; 1998 Aug; 8(4):343-51. PubMed ID: 9731721
[TBL] [Abstract][Full Text] [Related]
14. Analysis of CYP1A1 and COMT polymorphisms in women with cervical cancer.
Kleine JP; Camargo-Kosugi CM; Carvalho CV; Silva FC; Silva ID
Genet Mol Res; 2015 Dec; 14(4):18965-73. PubMed ID: 26782546
[TBL] [Abstract][Full Text] [Related]
15. CYP2D6 and CYP1A1 mutations in the Turkish population.
Aydin M; Hatirnaz O; Erensoy N; Ozbek U
Cell Biochem Funct; 2005; 23(2):133-5. PubMed ID: 15648054
[TBL] [Abstract][Full Text] [Related]
16. Genetic Polymorphisms of the Human Cytochrome P450 1A1 (CYP1A1) and Cervical Cancer Susceptibility among Northeast Thai Women.
Wongpratate M; Ishida W; Phuthong S; Natphopsuk S; Ishida T
Asian Pac J Cancer Prev; 2020 Jan; 21(1):243-248. PubMed ID: 31983191
[TBL] [Abstract][Full Text] [Related]
17. CYP1A1 MspI Polymorphism and Cervical Carcinoma Risk in the Multi-Ethnic Population of Malaysia: a Case-Control Study.
Tan YH; Sidik SM; Syed Husain SN; Lye MS; Chong PP
Asian Pac J Cancer Prev; 2016; 17(1):57-64. PubMed ID: 26838255
[TBL] [Abstract][Full Text] [Related]
18. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility.
Chen HC; Hu WX; Liu QX; Li WK; Chen FZ; Rao ZZ; Liu XF; Luo YP; Cao YF
Eur J Cancer Prev; 2008 Jun; 17(3):251-8. PubMed ID: 18414197
[TBL] [Abstract][Full Text] [Related]
20. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]